is a privately owned company and its businesses are organised into three areas.

Opal specialises in the development and supply of customised, high value injectable drugs for hospital and specialist applications. Sourcing generics to develop worldwide, Opal creates unique dosage and packaging forms. These incorporate novel delivery technology to provide flexibility and ease-of-use for hospital physicians, pharmacists and patients.
Opal's technical capability is underpinned by a successful commercial strategy utilising a global network of manufacturers and analytical support. Opal has traded profitably in all years since incorporation in 2002. Already a recognised supplier to the UK National Health Service, other European countries and the Middle East, Opal has a growing portfolio of antibiotic, cardiovascular and anti-fungal products with developments in other therapeutic areas.
Latest News >>
Investor Relations >>
Registered office: 19-21 Chapel Street, Marlow, Buckinghamshire, SL7 3HN Company registration number: 4318075

Text Only summary for Opal Health Care Ltd

Generic Pharmaceutical Manufacturer and Wholesaler

Opal Healthcare Limited is a Generic Pharmaceutical Manufacturer and wholesaler specialising in niche hospital prescription products. The Company's developments as Pharmaceutical Manufacturers include pharmaceutical trading, international export, European import and UK NHS tendering of Generic Pharmaceutical products. Opal Generics Limited is focused on developing a range of specialist hospital generic products. Opal's long-term business will be consolidated by building collaborations with other pharmaceutical companies and pharmaceutical wholesalers, biotechnology companies and universities for in-licencing, out-licencing products and the development and investment of new molecules in areas such as oncology and infectious diseases. For more information on Generic Pharmaceutical Manufacturer and Wholesalers please click the link.

Antibiotic Medical Supply

As a matter of strategic policy Opal is continuously exploring new investment relationships and business collaborations in antibiotic medical supply and generic pharmaceutical products. In doing so it seeks to maximise the potential of its existing and developing products as well as its extensive pharmaceutical marketing expertise and resources relating to antibiotic medical supply. For more information on Antibiotic Medical Supplies please click the link.

Pharmaceutical Injectables

Opal is a privately owned pharmaceutical company utilising its own profits for research and development in Pharmaceutical Injectables, which is leading to consistent business expansion and diversification. The company has successfully secured three rounds of funding in its first 18 months of trading to a value of £1.5 million which help in the development of new Injectables. For more information about Pharmaceutical Injectables please click the link.

Amiodarone

Amiodarone is the most effective, and certainly the strangest, anti arrhythmic drug ever developed. Anyone being treated with amiodarone should understand the idiosyncrasies - and the risks - associated with this highly effective drug. For more information on Amiodarones please click the link. Amiodarone should be used for arrhythmias that are life-threatening or that are very disruptive to one's life, and for which there are no other reasonable therapies.

Ofloxacin

Opal Healthcare Ltd has launched Ofloxacin 200mg & 400mg in the UK and there are further products in registration in cardiovascular, anti-infective and anti-fungal therapeutic areas. If you are interested in acting as a Ofloxacin distributor or sub-licensee please contact Opal's Business Development department.

Pharmaceutical Wholesaler | Pharmaceutical Manufacturers | Ofloxacin | Generic Pharmaceutical Manufacturer
Generic Pharmaceutical | Generic Pharmaceutical Product | Antibiotic Medical Supply
Injectables | Pharmaceutical Injectables | Amiodarone

RSS | HTML Sitemap | XML Sitemap

Valid HTML 4.01!